/

Società

Ab

Non verificato

Abzena

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaSanitàStart-up

9 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

22/07/2025

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Fonte

Emittente

1.00

0

15/05/2025

Farmaceutica

Sanità

Economia

Management

Organizzazione Aziendale

Abzena Announces Establishment of Scientific Advisory Board to Support Innovation Strategy

Fonte

Emittente

1.00

0

26/02/2025

Farmaceutica

Information Technology

Telecomunicazioni

Sanità

Economia

Management

Organizzazione Aziendale

Biologia

Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd as CBO

Fonte

Emittente

1.00

0

08/01/2025

Farmaceutica

Sanità

Economia

Management

Organizzazione Aziendale

Biologia

Abzena Strengthens Board with Appointment of Biopharma Industry Leader, Dr Moncef Slaoui

Fonte

Emittente

1.00

0

19/11/2024

Farmaceutica

Sanità

Economia

Start-up

Biologia

Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing Across US & UK Sites

Fonte

Emittente

1.00

0

30/10/2024

Farmaceutica

Sanità

Economia

Start-up

Biologia

Abzena Announces Major Expansion in Microbiology Laboratory Space in Support of Biologic Manufacturing

Fonte

Emittente

1.00

0

26/09/2024

Farmaceutica

Sanità

Economia

Start-up

Biologia

AbZelectPRO(TM) enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L

Fonte

Emittente

1.00

0

08/08/2024

Farmaceutica

Sanità

Biologia

Abzena Supplies Clinical Trial Material for Angiex's Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC

Fonte

Emittente

1.00

0

20/06/2024

Farmaceutica

Sanità

Economia

Start-up

Biologia

Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0